Sort
15,842 grants matching “pancreatic cancer”
Augmenting cancer checkpoint immunotherapies via microbially-derived metabolites
$142,625Matthew Everett Griffin · University Of California-Irvine · K22 · FY2025 · CA
Augmenting cancer checkpoint immunotherapies via microbially-derived metabolites
$142,625Matthew Everett Griffin · University Of California-Irvine · K22 · FY2024 · CA
Genomic Instability and The Roles of P53 and P19arf in Pancreatic Cancer
$142,560Aram F Hezel · Massachusetts General Hospital · K08 · FY2008 · CA
Core C: Biostatistical Core
$142,551Graham A Colditz · Washington University · P50 · FY2019 · CA
Targeting the Unfolded Protein Response in PanNETs
$142,406Scott A Oakes · University Of Chicago · R01 · FY2019 · CA
Zebrafish studies of exocrine pancreatic precursors
$142,375Johns Hopkins University · R21 · FY2004 · DK
OT::IGF::OT A phase I single-arm, multicenter pilot study aimed at validating y-OHPdG as a biomarker and testing the effects of Polyphenon E on its levels in patients with cirrhosis
$142,319Seema Khan · Northwestern University At Chicago · N01 · FY2019 · CA
Investigation of the mitochondrial function in GNAS mutant neoplasms
$142,249Krushna Chandra Patra · University Of Cincinnati · K22 · FY2023 · CA
SAMBAI - Establishing a comprehensive assessment of contributors to cancer inequities across the African diaspora
$142,189Tiffany Lashaun Carson · H. Lee Moffitt Cancer Ctr & Res Inst · OT2 · FY2024 · CA
Multifactor risk scores with susceptibility gene mutations to enhance risk assessment of pancreatic cancer
$142,096Ann Laura Oberg · Mayo Clinic Rochester · R01 · FY2024 · CA
Administrative Core
$142,092Donald J Buchsbaum · University Of Alabama At Birmingham · P50 · FY2012 · CA
Fresno State-SBCC Partnership:Cancer Research & Training for Central CA (2 of 2)
$142,087Kristiina Vuori · Sanford Burnham Prebys Medical Discovery Institute · P20 · FY2012 · CA
OT::IGF::OT A phase I single-arm, multicenter pilot study aimed at validating y-OHPdG as a biomarker and testing the effects of Polyphenon E on its levels in patients with cirrhosis
$142,069Seema Khan · Northwestern University At Chicago · N01 · FY2021 · CA
Project 1: Defining Mechanisms of MICAL-dependent Pancreatic Cancer Cell Migration
$141,943Parag Katira · San Diego State University · U54 · FY2024 · CA
Role of pH-mediated metabolic reprogramming in β cell failure in Type 2 Diabetes Mellitus
$141,941Aleksey V Matveyenko · Mayo Clinic Rochester · R01 · FY2023 · DK
Proteomics Core
$141,862Reid Townsend · Washington University · P30 · FY2013 · CA
Genomic Instability and The Roles of P53 and P19arf in Pancreatic Cancer
$141,750Aram F Hezel · Massachusetts General Hospital · K08 · FY2007 · CA
ROLES OF OST3/6 THIOL OXIDOREDUCTASES IN N-LINKED PROTEIN GLYCOS/REDOX HOMEOSTAS
$141,686Dmitri Fomenko · University Of Nebraska Lincoln · P20 · FY2010 · RR
Randomized Trial of EUS Neurolysis in Pancreas Cancer
$141,448Mayo Clinic Jacksonville · R03 · FY2005 · DK
The role of FoxM1 in pancreatic cancer
$141,300Andrei L Gartel · University Of Illinois At Chicago · R21 · FY2008 · CA
Normal Cellular Prion Protein in Pancreatic Cancer
$141,300Man-Sun M Sy · Case Western Reserve University · R21 · FY2009 · CA
Nanoparticles Targeting Pancreatic Cancer
$141,220Dennis E Hallahan · Vanderbilt University · R21 · FY2008 · CA
Nanoparticles Targeting Pancreatic Cancer
$141,220Dennis E Hallahan · Vanderbilt University · R21 · FY2007 · CA
Cancer Therapeutics Program
$141,104Caryn Lerman · University Of Pennsylvania · P30 · FY2015 · CA
Fresno State-SBCC Partnership:Cancer Research & Training for Central CA (2 of 2)
$141,072Kristiina Vuori · Sanford Burnham Prebys Medical Discovery Institute · P20 · FY2011 · CA